{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:30:31Z","timestamp":1785879031520,"version":"3.56.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005296","name":"Universit\u00e4tsklinikum Regensburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005296","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metabolomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disorder characterized by progressive renal cyst formation, often leading to end-stage kidney disease (ESKD). In contrast to the urinary metabolome in ADPKD, the composition of renal cyst fluid remains largely unexplored.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted a comprehensive metabolomic analysis of renal cyst fluid from 26 ADPKD patients (20 on dialysis, six with kidney transplants) using \u00b9H-NMR spectroscopy and liquid chromatography-mass spectrometry (LC-MS). Cysts were clustered based on metabolite profiles, and differences were analyzed across groups defined by renal function status (dialysis vs. transplant), cyst volume, and cyst fluid sodium concentrations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Dialysis patients and transplant recipients differed significantly in their renal cyst fluid metabolomes. The former exhibited higher concentrations of myoinositol, creatinine, sucrose, \u03c4-methylhistidine, trigonelline, and sarcosine, while the latter showed increased levels of leucine, isoleucine, valine and alanine. Remarkably, metabolites of the immunosuppressive prodrug mycophenolate mofetil were detected in renal cyst fluids after kidney transplantation. Despite intra- and interindividual variability, cyst fluid from the same patient displayed greater homogeneity. Interestingly, metabolomic profiles were not altered by cyst size.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This first systematic metabolomic analysis of renal cyst fluid in advanced ADPKD reveals distinct metabolic signatures linked to renal function status. The data provides novel insights into the pathophysiology of ADPKD and highlight the potentials of renal cyst fluid metabolomics for identifying biomarkers and therapeutic targets.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11306-025-02291-7","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T05:48:18Z","timestamp":1750916898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Metabolomic profiling of renal cyst fluid in advanced ADPKD: insights from dialysis and transplantation cohorts"],"prefix":"10.1007","volume":"21","author":[{"given":"Simon","family":"Heckscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas A.","family":"Ihlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Schueler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Kellermeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens M.","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Nuebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Wullich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kammerl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Gnewuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Burkhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Buchholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Pion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiha","family":"Aung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Banas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J.","family":"Schlitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Oefner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Dettmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Gronwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merle","family":"Behr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Haerteis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina M.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"2291_CR1","doi-asserted-by":"crossref","unstructured":"Al Khunaizi, A., & Alam, A. (2018). End-Stage Renal Disease in Patients with Autosomal Dominant Polycystic Kidney Disease. In: Benjamin D. Cowley, JR und John J. Bissler (Hg.) Polycystic Kidney Disease: Translating Mechanisms into Therapy. New York, NY: Springer New York, S. 229\u2013241.","DOI":"10.1007\/978-1-4939-7784-0_14"},{"key":"2291_CR2","doi-asserted-by":"publisher","first-page":"106794","DOI":"10.1016\/j.phrs.2023.106794","volume":"192","author":"H Aouad","year":"2023","unstructured":"Aouad, H., Faucher, Q., Sauvage, F. L., Pinault, E., Barrot, C. C., Arnion, H., et al. (2023). A multi-omics investigation of tacrolimus off-target effects on a proximal tubule cell-line. Pharmacological Research, 192, 106794. https:\/\/doi.org\/10.1016\/j.phrs.2023.106794","journal-title":"Pharmacological Research"},{"key":"2291_CR3","doi-asserted-by":"publisher","first-page":"1126055","DOI":"10.3389\/fmolb.2023.1126055","volume":"10","author":"I Bakaj","year":"2023","unstructured":"Bakaj, I., & Pocai, A. (2023). Metabolism-based approaches for autosomal dominant polycystic kidney disease. Front Mol Biosci, 10, 1126055. https:\/\/doi.org\/10.3389\/fmolb.2023.1126055","journal-title":"Front Mol Biosci"},{"key":"2291_CR4","doi-asserted-by":"publisher","unstructured":"Bevilacqua, A., & Bizzarri, M. (2018). Inositols in Insulin Signaling and Glucose Metabolism. In: Int J Endocrinol 2018, S. 1968450. https:\/\/doi.org\/10.1155\/2018\/1968450","DOI":"10.1155\/2018\/1968450"},{"key":"2291_CR5","doi-asserted-by":"publisher","unstructured":"Bichlmayer, E. M., Mahl, L., Hesse, L., Pion, E., Haller, V., Moehwald, A., et al. (2022). A 3D in vivo model for studying human renal cystic tissue and mouse kidney slices. Cells, 11(15). https:\/\/doi.org\/10.3390\/cells11152269","DOI":"10.3390\/cells11152269"},{"issue":"2","key":"2291_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0002-9343(55)90236-9","volume":"18","author":"NS Bricker","year":"1955","unstructured":"Bricker, N. S., & Patton, J. F. (1955). Cystic disease of the kidneys; a study of dynamics and chemical composition of cyst fluid. American Journal of Medicine, 18(2), 207\u2013219. https:\/\/doi.org\/10.1016\/0002-9343(55)90236-9","journal-title":"American Journal of Medicine"},{"key":"2291_CR7","doi-asserted-by":"publisher","unstructured":"Broseta, J. J., Roca, M., Rodr\u00edguez-Espinosa, D., L\u00f3pez-Romero, L. C., G\u00f3mez-Bori, A., Cuadrado-Pay\u00e1n, E., et al. (2022). Impact of acetate versus citrate dialysates on intermediary Metabolism-A targeted metabolomics approach. International Journal of Molecular Sciences, 23(19). https:\/\/doi.org\/10.3390\/ijms231911693","DOI":"10.3390\/ijms231911693"},{"issue":"6","key":"2291_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","volume":"34","author":"RE Bullingham","year":"1998","unstructured":"Bullingham, R. E., Nicholls, A. J., & Kamm, B. R. (1998). Clinical pharmacokinetics of mycophenolate mofetil. Clinical Pharmacokinetics, 34(6), 429\u2013455. https:\/\/doi.org\/10.2165\/00003088-199834060-00002","journal-title":"Clinical Pharmacokinetics"},{"issue":"10","key":"2291_CR9","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/nbt.2377","volume":"30","author":"MC Chambers","year":"2012","unstructured":"Chambers, M. C., Maclean, B., Burke, R., Amodei, D., Ruderman, D. L., Neumann, S., et al. (2012). A cross-platform toolkit for mass spectrometry and proteomics. Nature Biotechnology, 30(10), 918\u2013920. https:\/\/doi.org\/10.1038\/nbt.2377","journal-title":"Nature Biotechnology"},{"key":"2291_CR10","doi-asserted-by":"publisher","unstructured":"Chapman, A. B., Devuyst, O., Eckardt, K. U., Gansevoort, R. T., Harris, T., Horie, S. (2015). Autosomal-dominant polycystic kidney disease (ADPKD) executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. In: Kidney Int 88 (1), S. 17\u201327. https:\/\/doi.org\/10.1038\/ki.2015.59","DOI":"10.1038\/ki.2015.59"},{"issue":"11","key":"2291_CR11","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1007\/s003300000601","volume":"10","author":"PL Choyke","year":"2000","unstructured":"Choyke, P. L. (2000). Acquired cystic kidney disease. European Radiology, 10(11), 1716\u20131721. https:\/\/doi.org\/10.1007\/s003300000601","journal-title":"European Radiology"},{"issue":"10174","key":"2291_CR12","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/s0140-6736(18)32782-x","volume":"393","author":"E Cornec-Le Gall","year":"2019","unstructured":"Cornec-Le Gall, E., Alam, A., & Perrone, R. D. (2019). Autosomal dominant polycystic kidney disease. Lancet, 393(10174), 919\u2013935. https:\/\/doi.org\/10.1016\/s0140-6736(18)32782-x","journal-title":"Lancet"},{"issue":"6","key":"2291_CR13","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1159\/000524851","volume":"53","author":"SEI Dekker","year":"2022","unstructured":"Dekker, S. E. I., Verhoeven, A., Frey, D., Soonawala, D., Peters, D. J. M., Mayboroda, O. A., & de Fijter, J. W. (2022). Change in urinary myoinositol\/citrate ratio associates with progressive loss of renal function in ADPKD patients. American Journal of Nephrology, 53(6), 470\u2013480. https:\/\/doi.org\/10.1159\/000524851","journal-title":"American Journal of Nephrology"},{"key":"2291_CR14","doi-asserted-by":"publisher","unstructured":"Dekker, S. E. I., Verhoeven, A., Soonawala, D., Peters, D. J. M., & Fijter, J. W. (2020). Urinary metabolites associate with the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease. PLoS One, 15(5). https:\/\/doi.org\/10.1371\/journal.pone.0233213. MayborodaO. A.e0233213.","DOI":"10.1371\/journal.pone.0233213"},{"issue":"13","key":"2291_CR15","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1021\/ac051632c","volume":"78","author":"F Dieterle","year":"2006","unstructured":"Dieterle, F., Ross, A., Schlotterbeck, G., & Senn, H. (2006). Probabilistic quotient normalization as robust method to account for Dilution of complex biological mixtures. Application in 1H NMR metabonomics. Analytical Chemistry, 78(13), 4281\u20134290. https:\/\/doi.org\/10.1021\/ac051632c","journal-title":"Analytical Chemistry"},{"issue":"4","key":"2291_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0925-4439(92)90008-b","volume":"1138","author":"PJ Foxall","year":"1992","unstructured":"Foxall, P. J., Price, R. G., Jones, J. K., Neild, G. H., Thompson, F. D., & Nicholson, J. K. (1992). High resolution proton magnetic resonance spectroscopy of cyst fluids from patients with polycystic kidney disease. Biochimica Et Biophysica Acta, 1138(4), 305\u2013314. https:\/\/doi.org\/10.1016\/0925-4439(92)90008-b","journal-title":"Biochimica Et Biophysica Acta"},{"key":"2291_CR17","doi-asserted-by":"publisher","unstructured":"Fragiadaki, M., Macleod, F. M., & Ong, A. C. M. (2020). The controversial role of fibrosis in autosomal dominant polycystic kidney disease. International Journal of Molecular Sciences, 21(23). https:\/\/doi.org\/10.3390\/ijms21238936","DOI":"10.3390\/ijms21238936"},{"issue":"18","key":"2291_CR18","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1056\/nejm196910302811804","volume":"281","author":"KD Gardner","year":"1969","unstructured":"Gardner, K. D. (1969). Composition of fluid in twelve cysts of a polycystic kidney. New England Journal of Medicine, 281(18), 985\u2013988. https:\/\/doi.org\/10.1056\/nejm196910302811804","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"2291_CR19","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/ki.1992.405","volume":"42","author":"KD Gardner","year":"1992","unstructured":"Gardner, K. D., Burnside, J. S., Skipper, B. J., Swan, S. K., Bennett, W. M., Connors, B. A., & Evan, A. P. (1992). On the probability that kidneys are different in autosomal dominant polycystic disease. Kidney International, 42(5), 1199\u20131206. https:\/\/doi.org\/10.1038\/ki.1992.405","journal-title":"Kidney International"},{"issue":"1098","key":"2291_CR20","doi-asserted-by":"publisher","first-page":"20190078","DOI":"10.1259\/bjr.20190078","volume":"92","author":"P Gaur","year":"2019","unstructured":"Gaur, P., Gedroyc, W., & Hill, P. (2019). ADPKD-what the radiologist should know. British Journal of Radiology, 92(1098), 20190078. https:\/\/doi.org\/10.1259\/bjr.20190078","journal-title":"British Journal of Radiology"},{"issue":"12","key":"2291_CR21","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1093\/ndt\/gfy020","volume":"33","author":"RB Gil","year":"2018","unstructured":"Gil, R. B., Ortiz, A., Sanchez-Ni\u00f1o, M. D., Markoska, K., Schepers, E., Vanholder, R., et al. (2018). Increased urinary osmolyte excretion indicates chronic kidney disease severity and progression rate. Nephrology, Dialysis, Transplantation, 33(12), 2156\u20132164. https:\/\/doi.org\/10.1093\/ndt\/gfy020","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"10","key":"2291_CR22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nrneph.2011.109","volume":"7","author":"JJ Grantham","year":"2011","unstructured":"Grantham, J. J., Mulamalla, S., & Swenson-Fields, K. I. (2011). Why kidneys fail in autosomal dominant polycystic kidney disease. Nature Reviews Nephrology, 7(10), 556\u2013566. https:\/\/doi.org\/10.1038\/nrneph.2011.109","journal-title":"Nature Reviews Nephrology"},{"issue":"23","key":"2291_CR23","doi-asserted-by":"publisher","first-page":"9288","DOI":"10.1021\/ac801627c","volume":"80","author":"W Gronwald","year":"2008","unstructured":"Gronwald, W., Klein, M. S., Kaspar, H., Fagerer, S. R., N\u00fcrnberger, N., Dettmer, K., et al. (2008). Urinary metabolite quantification employing 2D NMR spectroscopy. Analytical Chemistry, 80(23), 9288\u20139297. https:\/\/doi.org\/10.1021\/ac801627c","journal-title":"Analytical Chemistry"},{"issue":"11","key":"2291_CR24","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/ki.2011.30","volume":"79","author":"W Gronwald","year":"2011","unstructured":"Gronwald, W., Klein, M. S., Zeltner, R., Schulze, B. D., Reinhold, S. W., Deutschmann, M., et al. (2011). Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine. Kidney International, 79(11), 1244\u20131253. https:\/\/doi.org\/10.1038\/ki.2011.30","journal-title":"Kidney International"},{"issue":"3","key":"2291_CR25","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ekir.2022.11.019","volume":"8","author":"KR Hallows","year":"2023","unstructured":"Hallows, K. R., Abebe, K. Z., Li, H., Saitta, B., Althouse, A. D., Bae, K. T., et al. (2023). Association of longitudinal urinary metabolic biomarkers with ADPKD severity and response to Metformin in TAME-PKD clinical trial participants. Kidney Int Rep, 8(3), 467\u2013477. https:\/\/doi.org\/10.1016\/j.ekir.2022.11.019","journal-title":"Kidney Int Rep"},{"key":"2291_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","volume":"60","author":"PC Harris","year":"2009","unstructured":"Harris, P. C., & Torres, V. E. (2009). Polycystic kidney disease. Annual Review of Medicine, 60, 321\u2013337. https:\/\/doi.org\/10.1146\/annurev.med.60.101707.125712","journal-title":"Annual Review of Medicine"},{"key":"2291_CR27","doi-asserted-by":"publisher","unstructured":"Haumann, S., M\u00fcller, R. U., & Liebau, M. C. (2020). Metabolic changes in polycystic kidney disease as a potential target for systemic treatment. International Journal of Molecular Sciences, 21(17). https:\/\/doi.org\/10.3390\/ijms21176093","DOI":"10.3390\/ijms21176093"},{"issue":"6","key":"2291_CR28","doi-asserted-by":"publisher","first-page":"F590","DOI":"10.1152\/ajprenal.00301.2022","volume":"324","author":"EA Houske","year":"2023","unstructured":"Houske, E. A., Glimm, M. G., Bergstrom, A. R., Slipher, S. K., Welhaven, H. D., Greenwood, M. C., et al. (2023). Metabolomic profiling to identify early urinary biomarkers and metabolic pathway alterations in autosomal dominant polycystic kidney disease. Am J Physiol Renal Physiol, 324(6), F590\u2013f602. https:\/\/doi.org\/10.1152\/ajprenal.00301.2022","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"2291_CR29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/ki.1980.148","volume":"18","author":"R Huseman","year":"1980","unstructured":"Huseman, R., Grady, A., Welling, D., & Grantham, J. (1980). Macropuncture study of polycystic disease in adult human kidneys. Kidney International, 18(3), 375\u2013385. https:\/\/doi.org\/10.1038\/ki.1980.148","journal-title":"Kidney International"},{"issue":"1","key":"2291_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/ndt\/gfv227","volume":"31","author":"Y Jung","year":"2016","unstructured":"Jung, Y., Irazabal, M. V., Chebib, F. T., Harris, P. C., Dean, P. G., Prieto, M., et al. (2016). Volume regression of native polycystic kidneys after renal transplantation. Nephrology, Dialysis, Transplantation, 31(1), 73\u201379. https:\/\/doi.org\/10.1093\/ndt\/gfv227","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"1","key":"2291_CR31","doi-asserted-by":"publisher","first-page":"F204","DOI":"10.1152\/ajprenal.00470.2018","volume":"316","author":"AT Kenter","year":"2019","unstructured":"Kenter, A. T., van Rossum-Fikkert, S. E., Salih, M., Verhagen, P., van Leenders, G., Demmers, J. A. A., et al. (2019). Identifying cystogenic paracrine signaling molecules in cyst fluid of patients with polycystic kidney disease. Am J Physiol Renal Physiol, 316(1), F204\u2013f213. https:\/\/doi.org\/10.1152\/ajprenal.00470.2018","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7\u20138","key":"2291_CR32","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1002\/prca.200780140","volume":"2","author":"X Lai","year":"2008","unstructured":"Lai, X., Bacallao, R. L., Blazer-Yost, B. L., Hong, D., Mason, S. B., & Witzmann, F. A. (2008). Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients. Proteomics. Clinical Applications, 2(7\u20138), 1140\u20131152. https:\/\/doi.org\/10.1002\/prca.200780140","journal-title":"Proteomics. Clinical Applications"},{"issue":"1","key":"2291_CR33","first-page":"34","volume":"44","author":"PP Lambert","year":"1947","unstructured":"Lambert, P. P. (1947). Polycystic disease of the kidney; a review. Arch Pathol (Chic), 44(1), 34\u201358.","journal-title":"Arch Pathol (Chic)"},{"issue":"3","key":"2291_CR34","doi-asserted-by":"publisher","first-page":"100036","DOI":"10.1016\/j.jnha.2023.100036","volume":"28","author":"Y Liu","year":"2024","unstructured":"Liu, Y., Sun, M., Sun, J., Lin, F., Xu, D., Chen, Y., et al. (2024). Identification of novel serum metabolic signatures to predict chronic kidney disease among Chinese elders using UPLC-Orbitrap-MS. The Journal of Nutrition, Health & Aging, 28(3), 100036. https:\/\/doi.org\/10.1016\/j.jnha.2023.100036","journal-title":"The Journal of Nutrition, Health & Aging"},{"issue":"2","key":"2291_CR35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/j.jrn.2007.11.011","volume":"18","author":"S Ma\u0142gorzewicz","year":"2008","unstructured":"Ma\u0142gorzewicz, S., Debska-Slizie\u0144, A., Rutkowski, B., & Lysiak-Szyd\u0142owska, W. (2008). Serum concentration of amino acids versus nutritional status in Hemodialysis patients. Journal of Renal Nutrition: the official Journal of the Council on Renal Nutrition of the National Kidney Foundation, 18(2), 239\u2013247. https:\/\/doi.org\/10.1053\/j.jrn.2007.11.011","journal-title":"Journal of Renal Nutrition: the official Journal of the Council on Renal Nutrition of the National Kidney Foundation"},{"issue":"7","key":"2291_CR36","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/bf03343761","volume":"23","author":"P Marchetti","year":"2000","unstructured":"Marchetti, P., & Navalesi, R. (2000). The metabolic effects of cyclosporin and tacrolimus. J Endocrinol Invest, 23(7), 482\u2013490. https:\/\/doi.org\/10.1007\/bf03343761","journal-title":"J Endocrinol Invest"},{"key":"2291_CR37","doi-asserted-by":"crossref","unstructured":"McInnes, L., & Healy, J. (2018). UMAP: Uniform manifold approximation and projection for dimension reduction. \tarXiv:1802.03426","DOI":"10.21105\/joss.00861"},{"key":"2291_CR38","doi-asserted-by":"publisher","first-page":"988989","DOI":"10.3389\/fmed.2022.988989","volume":"9","author":"JW Meeusen","year":"2022","unstructured":"Meeusen, J. W., St\u00e4mmler, F., Dasari, S., Schiffer, E., & Lieske, J. C. (2022). Serum myo-inositol and valine improve metabolomic-based estimated glomerular filtration rate among kidney transplant recipients. Front Med (Lausanne), 9, 988989. https:\/\/doi.org\/10.3389\/fmed.2022.988989","journal-title":"Front Med (Lausanne)"},{"key":"2291_CR39","doi-asserted-by":"publisher","unstructured":"Merino, B., Fern\u00e1ndez-D\u00edaz, C. M., C\u00f3zar-Castellano, I., & Perdomo, G. (2019). Intestinal Fructose and glucose metabolism in health and disease. Nutrients, 12(1). https:\/\/doi.org\/10.3390\/nu12010094","DOI":"10.3390\/nu12010094"},{"issue":"3","key":"2291_CR40","doi-asserted-by":"publisher","first-page":"100856","DOI":"10.1016\/j.trre.2024.100856","volume":"38","author":"L Oliveras","year":"2024","unstructured":"Oliveras, L., Coloma, A., Lloberas, N., Lino, L., Fav\u00e0, A., Manonelles, A., et al. (2024). Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: A systematic review and meta-analysis. Transplantation Reviews (Orlando, Fla.), 38(3), 100856. https:\/\/doi.org\/10.1016\/j.trre.2024.100856","journal-title":"Transplantation Reviews (Orlando, Fla.)"},{"issue":"9","key":"2291_CR41","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/clinchem\/hvae097","volume":"70","author":"CL Omosule","year":"2024","unstructured":"Omosule, C. L., Blair, C. J., Herries, E., Zaydman, M. A., Farnsworth, C., Ladenson, J., et al. (2024). Clinical utility of LC-MS\/MS for blood Myo-Inositol in patients with acute kidney injury and chronic kidney disease. Clinical Chemistry, 70(9), 1172\u20131181. https:\/\/doi.org\/10.1093\/clinchem\/hvae097","journal-title":"Clinical Chemistry"},{"issue":"3","key":"2291_CR42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3109\/00498254.2012.713531","volume":"43","author":"CG Patel","year":"2013","unstructured":"Patel, C. G., Ogasawara, K., & Akhlaghi, F. (2013). Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus. Xenobiotica, 43(3), 229\u2013235. https:\/\/doi.org\/10.3109\/00498254.2012.713531","journal-title":"Xenobiotica"},{"issue":"6","key":"2291_CR43","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/wdev.152","volume":"3","author":"BM Paul","year":"2014","unstructured":"Paul, B. M., & Vanden Heuvel, G. B. (2014). Kidney: Polycystic kidney disease. Wiley Interdiscip Rev Dev Biol, 3(6), 465\u2013487. https:\/\/doi.org\/10.1002\/wdev.152","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"key":"2291_CR44","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/1471-2105-11-395","volume":"11","author":"T Pluskal","year":"2010","unstructured":"Pluskal, T., Castillo, S., Villar-Briones, A., & Oresic, M. (2010). MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. Bmc Bioinformatics, 11, 395. https:\/\/doi.org\/10.1186\/1471-2105-11-395","journal-title":"Bmc Bioinformatics"},{"issue":"4","key":"2291_CR45","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/sdi.12605","volume":"30","author":"F Rahbari-Oskoui","year":"2017","unstructured":"Rahbari-Oskoui, F., & O\u2019Neill, W. C. (2017). Diagnosis and management of acquired cystic kidney disease and renal tumors in ESRD patients. Seminars in dialysis, 30(4), 373\u2013379. https:\/\/doi.org\/10.1111\/sdi.12605","journal-title":"Seminars in dialysis"},{"key":"2291_CR46","doi-asserted-by":"publisher","unstructured":"Santos, I. S. R., Martin-Pastor, M., Tavares J\u00fanior, A. G., Queiroz, K. A., Da Silva S\u00f3lon, L. G., & Sousa, F. F. O. (2023). Metabolomic profile and its correlation with the plasmatic levels of losartan, EXP3174 and blood pressure control in hypertensive and chronic kidney disease patients. International Journal of Molecular Sciences, 24(12). https:\/\/doi.org\/10.3390\/ijms24129832","DOI":"10.3390\/ijms24129832"},{"issue":"1","key":"2291_CR47","doi-asserted-by":"publisher","first-page":"10063","DOI":"10.1038\/s41598-024-60783-3","volume":"14","author":"J Schueler","year":"2024","unstructured":"Schueler, J., Kuenzel, J., Thuesing, A., Pion, E., Behncke, R. Y., Haegerling, R., et al. (2024). Ultra high frequency ultrasound enables real-time visualization of blood supply from Chorioallantoic membrane to human autosomal dominant polycystic kidney tissue. Scientific Reports, 14(1), 10063. https:\/\/doi.org\/10.1038\/s41598-024-60783-3","journal-title":"Scientific Reports"},{"key":"2291_CR48","doi-asserted-by":"crossref","unstructured":"Seabold, S., & Perktold, J. (Hrsg.) (2010). Statsmodels: Econometric and Statistical Modeling with Python. SciPy.","DOI":"10.25080\/Majora-92bf1922-011"},{"issue":"1","key":"2291_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6002\/ect.2016.0157","volume":"15","author":"BM Shrestha","year":"2017","unstructured":"Shrestha, B. M. (2017). Two decades of tacrolimus in renal transplant: Basic science and clinical evidences. Experimental and Clinical Transplantation, 15(1), 1\u20139. https:\/\/doi.org\/10.6002\/ect.2016.0157","journal-title":"Experimental and Clinical Transplantation"},{"issue":"2","key":"2291_CR50","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/s0167-4889(97)00125-0","volume":"1401","author":"MJ Slade","year":"1998","unstructured":"Slade, M. J., Kirby, R. B., P\u00f3csi, I., Jones, J. K., & Price, R. G. (1998). Presence of laminin fragments in cyst fluid from patients with autosomal dominant polycystic kidney disease (ADPKD) role in proliferation of tubular epithelial cells. Biochimica Et Biophysica Acta, 1401(2), 203\u2013210. https:\/\/doi.org\/10.1016\/s0167-4889(97)00125-0","journal-title":"Biochimica Et Biophysica Acta"},{"key":"2291_CR51","doi-asserted-by":"publisher","unstructured":"Stegmayr, B. (2017). Dialysis procedures alter metabolic conditions. Nutrients, 9(6). https:\/\/doi.org\/10.3390\/nu9060548","DOI":"10.3390\/nu9060548"},{"issue":"4","key":"2291_CR52","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1152\/physrev.1998.78.4.1165","volume":"78","author":"LP Sullivan","year":"1998","unstructured":"Sullivan, L. P., Wallace, D. P., & Grantham, J. J. (1998). Epithelial transport in polycystic kidney disease. Physiological Reviews, 78(4), 1165\u20131191. https:\/\/doi.org\/10.1152\/physrev.1998.78.4.1165","journal-title":"Physiological Reviews"},{"issue":"5","key":"2291_CR53","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1158\/1055-9965.Epi-04-0827","volume":"14","author":"N Tasevska","year":"2005","unstructured":"Tasevska, N., Runswick, S. A., McTaggart, A., & Bingham, S. A. (2005). Urinary sucrose and Fructose as biomarkers for sugar consumption. Cancer Epidemiology, Biomarkers & Prevention, 14(5), 1287\u20131294. https:\/\/doi.org\/10.1158\/1055-9965.Epi-04-0827","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"10","key":"2291_CR54","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.bbadis.2011.01.011","volume":"1812","author":"S Terryn","year":"2011","unstructured":"Terryn, S., Ho, A., Beauwens, R., & Devuyst, O. (2011). Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease. Biochimica Et Biophysica Acta, 1812(10), 1314\u20131321. https:\/\/doi.org\/10.1016\/j.bbadis.2011.01.011","journal-title":"Biochimica Et Biophysica Acta"},{"key":"2291_CR55","doi-asserted-by":"publisher","unstructured":"Th\u00f6lking, G., Schulte, C., Jehn, U., Sch\u00fctte-N\u00fctgen, K., Pavenst\u00e4dt, H., Suwelack, B., & Reuter, S. (2021). The tacrolimus metabolism rate and dyslipidemia after kidney transplantation. J Clin Med, 10(14). https:\/\/doi.org\/10.3390\/jcm10143066","DOI":"10.3390\/jcm10143066"},{"issue":"10","key":"2291_CR56","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/j.1600-6143.2011.03686.x","volume":"11","author":"M Tonelli","year":"2011","unstructured":"Tonelli, M., Wiebe, N., Knoll, G., Bello, A., Browne, S., Jadhav, D., et al. (2011). Systematic review: Kidney transplantation compared with dialysis in clinically relevant outcomes. American Journal of Transplantation, 11(10), 2093\u20132109. https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03686.x","journal-title":"American Journal of Transplantation"},{"issue":"9569","key":"2291_CR57","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/s0140-6736(07)60601-1","volume":"369","author":"VE Torres","year":"2007","unstructured":"Torres, V. E., Harris, P. C., & Pirson, Y. (2007a). Autosomal dominant polycystic kidney disease. Lancet, 369(9569), 1287\u20131301. https:\/\/doi.org\/10.1016\/s0140-6736(07)60601-1","journal-title":"Lancet"},{"issue":"1","key":"2291_CR58","doi-asserted-by":"publisher","first-page":"112","DOI":"10.2215\/cjn.00910306","volume":"2","author":"VE Torres","year":"2007","unstructured":"Torres, V. E., King, B. F., Chapman, A. B., Brummer, M. E., Bae, K. T., Glockner, J. F., et al. (2007b). Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. Clinical Journal of the American Society of Nephrology, 2(1), 112\u2013120. https:\/\/doi.org\/10.2215\/cjn.00910306","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"12","key":"2291_CR59","doi-asserted-by":"publisher","first-page":"e0209332","DOI":"10.1371\/journal.pone.0209332","volume":"13","author":"M Veroux","year":"2018","unstructured":"Veroux, M., Gozzo, C., Corona, D., Murabito, P., Caltabiano, D. C., Mammino, L., et al. (2018). Change in kidney volume after kidney transplantation in patients with autosomal polycystic kidney disease. PLoS One, 13(12), e0209332. https:\/\/doi.org\/10.1371\/journal.pone.0209332","journal-title":"PLoS One"},{"issue":"3","key":"2291_CR60","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","volume":"17","author":"P Virtanen","year":"2020","unstructured":"Virtanen, P., Gommers, R., Oliphant, T. E., Haberland, M., Reddy, T., Cournapeau, D., et al. (2020). SciPy 1.0: Fundamental algorithms for scientific computing in Python. Nature Methods, 17(3), 261\u2013272. https:\/\/doi.org\/10.1038\/s41592-019-0686-2","journal-title":"Nature Methods"},{"issue":"60","key":"2291_CR61","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.21105\/joss.03021","volume":"6","author":"LM Waskom","year":"2021","unstructured":"Waskom, L. M. (2021). Seaborn: Statistical data visualization. Journal of Open Source Software, 6(60), 3021. https:\/\/doi.org\/10.21105\/joss.03021","journal-title":"Journal of Open Source Software"},{"issue":"10","key":"2291_CR62","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/j.biocel.2004.03.012","volume":"36","author":"PD Wilson","year":"2004","unstructured":"Wilson, P. D. (2004). Polycystic kidney disease: New Understanding in the pathogenesis. International Journal of Biochemistry & Cell Biology, 36(10), 1868\u20131873. https:\/\/doi.org\/10.1016\/j.biocel.2004.03.012","journal-title":"International Journal of Biochemistry & Cell Biology"},{"issue":"1","key":"2291_CR63","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s40360-022-00626-x","volume":"23","author":"D Xie","year":"2022","unstructured":"Xie, D., Guo, J., Dang, R., Li, Y., Si, Q., Han, W., et al. (2022). The effect of tacrolimus-induced toxicity on metabolic profiling in target tissues of mice. BMC Pharmacol Toxicol, 23(1), 87. https:\/\/doi.org\/10.1186\/s40360-022-00626-x","journal-title":"BMC Pharmacol Toxicol"},{"issue":"3","key":"2291_CR64","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/0272-6386(95)90111-6","volume":"25","author":"T Yamaguchi","year":"1995","unstructured":"Yamaguchi, T., Nagao, S., Takahashi, H., Ye, M., & Grantham, J. J. (1995). Cyst fluid from a murine model of polycystic kidney disease stimulates fluid secretion, Cyclic adenosine monophosphate accumulation, and cell proliferation by Madin-Darby canine kidney cells in vitro. American Journal of Kidney Diseases, 25(3), 471\u2013477. https:\/\/doi.org\/10.1016\/0272-6386(95)90111-6","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"2291_CR65","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11306-020-01762-3","volume":"17","author":"Y Yamaguchi","year":"2021","unstructured":"Yamaguchi, Y., Zampino, M., Moaddel, R., Chen, T. K., Tian, Q., Ferrucci, L., & Semba, R. D. (2021). Plasma metabolites associated with chronic kidney disease and renal function in adults from the Baltimore longitudinal study of aging. Metabolomics, 17(1), 9. https:\/\/doi.org\/10.1007\/s11306-020-01762-3","journal-title":"Metabolomics"},{"issue":"8","key":"2291_CR66","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1097\/TP.0b013e318246f910","volume":"93","author":"T Yamamoto","year":"2012","unstructured":"Yamamoto, T., Watarai, Y., Kobayashi, T., Matsuda, Y., Tsujita, M., Hiramitsu, T., et al. (2012). Kidney volume changes in patients with autosomal dominant polycystic kidney disease after renal transplantation. Transplantation, 93(8), 794\u2013798. https:\/\/doi.org\/10.1097\/TP.0b013e318246f910","journal-title":"Transplantation"},{"issue":"4","key":"2291_CR67","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1681\/asn.V34984","volume":"3","author":"M Ye","year":"1992","unstructured":"Ye, M., Grant, M., Sharma, M., Elzinga, L., Swan, S., Torres, V. E., & Grantham, J. J. (1992). Cyst fluid from human autosomal dominant polycystic kidneys promotes cyst formation and expansion by renal epithelial cells in vitro. Journal of the American Society of Nephrology, 3(4), 984\u2013994. https:\/\/doi.org\/10.1681\/asn.V34984","journal-title":"Journal of the American Society of Nephrology"}],"container-title":["Metabolomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-025-02291-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11306-025-02291-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-025-02291-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T15:06:01Z","timestamp":1757948761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11306-025-02291-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":67,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["2291"],"URL":"https:\/\/doi.org\/10.1007\/s11306-025-02291-7","relation":{},"ISSN":["1573-3890"],"issn-type":[{"value":"1573-3890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]},"assertion":[{"value":"25 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all subjects and\/or their legal guardians and experiments were approved by the ethics committee of the University of Regensburg (no. 20-1886-101) and of the Friedrich-Alexander-University Erlangen-Nuremberg (no. 23-404-Bn). All patient data gets encrypted, and every patient gets an internal patient ID. All data protection guidelines from the University of Regensburg are met.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree with the publication of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"90"}}